A systematic review and meta-analysis of the efficacy and safety of adalimumab for treating rheumatoid arthritis

被引:0
|
作者
Astrid Wiens
Cassyano Januário Correr
Rafael Venson
Michel Fleith Otuki
Roberto Pontarolo
机构
[1] Universidade Federal do Paraná,Pharmaceutical Practice Research Group, Pharmacy Department
[2] State Universidade de Ponta Grossa,Department of Pharmacology
来源
关键词
Adalimumab; Rheumatoid arthritis; Meta-analysis; Efficacy and safety;
D O I
暂无
中图分类号
学科分类号
摘要
Adalimumab (ADA) is a monoclonal antibody. Published studies indicate that its use in patients with rheumatoid arthritis can be efficient in providing long-term benefits. The aim of this study is to evaluate the efficacy and safety of ADA for treating rheumatoid arthritis. A systematic review was performed to search for randomized clinical trials that compare subcutaneous doses of ADA 20 mg weekly or 40 mg every other week with placebo, with or without concomitant methotrexate. Only studies of moderate or high quality were included. A meta-analysis was conducted to assess the efficacy (based in changes of American College of Rheumatology ACR criteria) and the safety (based in serious adverse events, serious infections, malignancy and deaths) of ADA use. Withdrawals due to adverse events or lack of efficacy were also evaluated. Eight studies met the inclusion criteria, comprising 2,692 patients. In the efficacy meta-analysis, a greater number of ADA-treated patients relative to those in placebo group achieved ACR20, ACR50 and ACR70 values from 6 months to 2 years of treatment. For safety results, there were no statistically significant differences between the groups. Withdrawals due to adverse events were higher in ADA group relative to the placebo group, and withdrawals due to the lack of efficacy were higher in placebo group relative to the ADA-treated group. This meta-analysis shows a higher efficacy of ADA relative to placebo, but clinicians should be careful regarding adverse events in ADA-treated patients.
引用
收藏
页码:1063 / 1070
页数:7
相关论文
共 50 条
  • [1] A systematic review and meta-analysis of the efficacy and safety of adalimumab for treating rheumatoid arthritis
    Wiens, Astrid
    Correr, Cassyano Januario
    Venson, Rafael
    Otuki, Michel Fleith
    Pontarolo, Roberto
    [J]. RHEUMATOLOGY INTERNATIONAL, 2010, 30 (08) : 1063 - 1070
  • [2] A Systematic Review and Meta-analysis of the Efficacy and Safety of Etanercept for Treating Rheumatoid Arthritis
    Wiens, Astrid
    Correr, Cassyano Januario
    Pontarolo, Roberto
    Venson, Rafael
    Quinalha, Juliana Vasconcelos
    Otuki, Michel Fleith
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 70 (04) : 337 - 344
  • [3] Safety and Efficacy of Mavrilimumab For Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Shamseldin, Laila Salah
    Shawqi, Mohamed Mohamed
    Al Hashem, Noor Adel
    Alhyari, Majd Aleslam Hussein
    Abd Elazeem, Hossam Aldein Samir
    Elghazaly, Shrouk M.
    Hamdallah, Aboalmagd
    Ragab, Khaled Mohamed
    Nourelden, Anas Zakarya
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2021, 17 (02) : 184 - 192
  • [4] Efficacy and safety of jakinibs in rheumatoid arthritis: a systematic review and meta-analysis
    Yin, Yufeng
    Liu, Mengru
    Zhou, Erye
    Chang, Xin
    He, Michun
    Wang, Mingjun
    Wu, Jian
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 3989 - 4005
  • [5] Efficacy and safety of jakinibs in rheumatoid arthritis: a systematic review and meta-analysis
    Yufeng Yin
    Mengru Liu
    Erye Zhou
    Xin Chang
    Michun He
    Mingjun Wang
    Jian Wu
    [J]. Clinical Rheumatology, 2021, 40 : 3989 - 4005
  • [6] Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis
    Ahamada, M. Mohamed
    Wu, X.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (09) : 1882 - 1900
  • [7] Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    He, Ying
    Wong, Angel Y. S.
    Chan, Esther W.
    Lau, Wallis C. Y.
    Man, Kenneth K. C.
    Chui, Celine S. L.
    Worsley, Alan J.
    Wong, Ian C. K.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [8] Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Ying He
    Angel YS Wong
    Esther W Chan
    Wallis CY Lau
    Kenneth KC Man
    Celine SL Chui
    Alan J Worsley
    Ian CK Wong
    [J]. BMC Musculoskeletal Disorders, 14
  • [9] Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - A systematic review and meta-analysis
    Kaneko, Yuko
    Kawahito, Yutaka
    Kojima, Masayo
    Nakayama, Takeo
    Hirata, Shintaro
    Kishimoto, Mitsumasa
    Endo, Hirahito
    Seto, Yohei
    Ito, Hiromu
    Nishida, Keiichiro
    Matsushita, Isao
    Kojima, Toshihisa
    Kamatani, Naoyuki
    Tsutani, Kiichiro
    Igarashi, Ataru
    Hasegawa, Mieko
    Miyasaka, Nobuyuki
    Yamanaka, Hisashi
    [J]. MODERN RHEUMATOLOGY, 2021, 31 (01) : 61 - 69
  • [10] Yoga for Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Ye, Xiangling
    Chen, Zehua
    Shen, Zhen
    Chen, Guocai
    Xu, Xuemeng
    [J]. FRONTIERS IN MEDICINE, 2020, 7